[Plasmapheresis in the treatment of complicated forms of acute suppurative pyelonephritis in pregnant women].
Plasmapheresis was carried out in the course of treatment of 46 19-28-year-old females (gestation 13-37 weeks) suffering from complicated acute purulent pyelonephritis (APP) versus 50 controls treated conventionally without plasmapheresis. Nonconventional scheme included antibacterial therapy, infusions, plasmapheresis, surgical interventions. The number of plasmapheresis sessions ranged from 3 to 6 per 1 patient depending on APP severity and efficacy of the treatment. Plasma removal reached 600-900 ml of plasma per session, a total of 2000-2600 ml per course of treatment. Introduction of plasmapheresis made it easier to manage pyoseptic intoxication, to achieve clinico- laboratory remission. The efficacy of treatment increased by 20%.
Dovlatian
A A
AA
Bentsianov
V A
VA
D000208:Acute Disease; D000328:Adult; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology / Q000628:therapy; D003131:Combined Modality Therapy; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D010956:Plasmapheresis; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy*; D011262:Pregnancy Trimester, Second; D011263:Pregnancy Trimester, Third; D011704:Pyelonephritis / Q000150:complications* / Q000628:therapy*; D051437:Renal Insufficiency / Q000209:etiology / Q000628:therapy; D018805:Sepsis / Q000209:etiology / Q000628:therapy
Plazmaferez v lechenii oslozhnennykh form ostrogo gnoĭnogo pielonefrita beremennykh.